“…Although no significant correlation (p > 0.05) could be found for all of the OMPs degradation with either of the photochemical properties or major functional groups, the OMPs could be degraded through the following major photodegradation routes suggested by Among the 75 OMPs evaluated in this study, information on degradation pathways is available for meclofenamic acid (photocyclisation), norfloxacin (photodehalogenation), , diclofenac (decarboxyllation), atenelol (hydroxylation) (Salgado et al, 2013), sulphamethoxazole (desulphonamidation, photoelimination, hydroxylation), amitryptiline (photohydration) (Nassar et al, 2017), tamoxifen (hydroxylation) (Ferrando-Climent et al, 2017), sertraline (dechlorination and dehydration) (Calza et al, 2021), salicyclic acid (hydroxylation) , rantidine (denitration) , oxazepam (hydroxylation) (Kosjek et al, 2012), diazepam (hydroxylation and demethylation) (Mitsika et al, 2021), cetirizine (dechlorination and dehydroxylation) and fexofenadine (deamination and dehydroxylation) (Liu et al, 2022). Additionally, Lin et al (2022) reported transformation pathways for antidepressants including citalopram, fluoxetine, sertraline and venlafaxine.…”